Archives

by in
Entry Author Date Location
Sarepta Drug Helps Boys With Duchenne to Walk; Shares Boom 10/03/12 Boston
Sarepta Moves From Seattle to Boston for the Talent 09/07/12 Seattle
Sarepta’s Muscular Dystrophy Drug Improves With Time; Stock Booms 07/24/12 Seattle
Halo Gathers $1.1M From Patient Groups for Muscular Dystrophy Drug 05/24/12 Boston
N-Gene Digs Up Funds to Boost “Heat Shock” Drug in Diabetes and MD 04/25/12 New York
AVI Biopharma Mulls Deal After Mixed Data With Muscular Dystrophy Drug 04/06/12 Seattle
AVI Biopharma Passes Small Study in Muscular Dystrophy 04/02/12 Seattle
AVI Biopharma Axes 28% of Workforce, After Missing Out on Flu Contract 12/12/11 Seattle
AVI Starts Duchenne Trial 08/15/11 Seattle
ASCO Wrap-Up, Pathway Medical Grinds It Out, Gates Foundation’s New Digs, & More in Seattle-Area Life Sciences News 06/09/11 Seattle
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company 06/02/11 Seattle
Regulus Names Chief Scientist 04/18/11 San Diego
Omeros Flunks Pivotal Trials, Dendreon’s Shareholder Hubbub, AVI Biopharma Nabs $30M, & More Seattle-Area Life Sciences News 04/07/11 Seattle
AVI Biopharma Adds $30M 04/01/11 Seattle
Dendreon Wins Medicare Coverage, Clarisonic Tops $100M in Sales, Sage Partners Up, & More Seattle-Area Life Sciences News 03/31/11 Seattle
AVI Biopharma Adds Chief Scientist 03/28/11 Seattle
The Immunex Alumni, Hood Wins Russ Prize, Williams Grabs Biogen Gig, & More Seattle-Area Life Sciences News 01/06/11 Seattle
AVI Partners With Karolinska 01/05/11 Seattle
Adaptive TCR Seeks to Dominate New Industry, Ultrasound on an iPhone, AVI Names CEO, & More Seattle-Area Life Sciences News 12/16/10 Seattle
AVI Names New CEO 12/13/10 Seattle
Acceleron Snags $498M Deal With Shire to Develop Muscular Dystrophy Drugs 09/09/10 Boston
Tekmira and AVI Win Ebola Deals, Mirador’s Idea to Prevent Hospital Errors, Tom Ranken’s New Mission, & More Seattle-Area Life Sciences News 07/22/10 Seattle
ZymoGenetics Gets Upstaged, Calistoga Cancer Drug Matures, Cramer Replaces Kraemer, & More Seattle-Area Life Sciences News 06/11/10 Seattle
AVI Biopharma Ousts CEO, CombiMatrix Drops Seattle Wing, Cell Therapeutics Cans 36 Workers, & More Seattle-Area Life Sciences News 04/22/10 Seattle
AVI Biopharma Ousts CEO Les Hudson in Boardroom Coup 04/21/10 Seattle
Cell Therapeutics Nears Judgment Day, AVI Biopharma Awaits Results, HemaQuest Gets $6M & More Seattle-Area Life Sciences News 02/04/10 Seattle
AVI Biopharma Eagerly Awaits Data on Muscular Dystrophy Drug 02/01/10 Seattle
A Brief Year-End Review of Seattle Biotech 12/31/09 Seattle
Cell Therapeutics Dangles Exec Bonuses, Oncothyreon’s Turnaround Year, VLST Layoffs, & More Seattle-Area Life Sciences News 12/24/09 Seattle
AVI Biopharma Drug Shows Hint of Effect Against Muscular Dystrophy In Small Study 12/22/09 Seattle
Page 1 of 3 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.